Search results for “Lymphocytic cell” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 620 patents, we discovered top 276 key players by total patent application. Novartis AG, MorphoSys AG, Janssen Pharmaceutica NV are dominant in this area. They take 12.74% of the total patent filing.
Novartis AG
Basel-Stadt, Switzerland
Patent: 31
MorphoSys AG
Bayern, Germany
Patent: 28
Janssen Pharmaceutica NV
Antwerpen, Belgium
Patent: 20
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 11
Yeda Research & Development Co. Ltd.
Israel
Patent: 10
GC Cell Corp.
South Korea
Patent: 9
Amgen Research (Munich) GmbH
Hessen, Germany
Patent: 9
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 8
Genzyme Corp.
Massachusetts, United States
Patent: 7
Bristol Myers Squibb Co.
New York, United States
Patent: 6
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 16 patents, we discovered top 5 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, DRAGONFLY Therapeutics, Inc., Jiangsu Quanxin Biomedical Co Ltd are active in this area.
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 12
STARTUP
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 1
STARTUP
Jiangsu Quanxin Biomedical Co Ltd
Jiangsu Sheng, China
Patent: 1
STARTUP
Immunophage
China
Patent: 1
STARTUP
Advita Lifescience GmbH
Bayern, Germany
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 415 patents applied in the last 5 years. We discover 234 most active companies in this area. The fast-growing MorphoSys AG, Novartis AG, Janssen Pharmaceutica NV take 10.36% of patent filing during this period.
MorphoSys AG
Bayern, Germany
Patent: 17
Novartis AG
Basel-Stadt, Switzerland
Patent: 14
Janssen Pharmaceutica NV
Antwerpen, Belgium
Patent: 12
GC Cell Corp.
South Korea
Patent: 9
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 7
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 7
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 5
Monoquant Pty Ltd
Australia
Patent: 5
MedImmune LLC
Louisiana, United States
Patent: 5
Regents of the University of California
California, United States
Patent: 4
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 415 patents in last 5 years, we discover 189 new entrants. GC Cell Corp., Immatics Biotechnologies GmbH, Monoquant Pty Ltd are the most active new entrants in this area.
GC Cell Corp.
South Korea
Patent: 9
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 5
Monoquant Pty Ltd
Australia
Patent: 5
Ramot at Tel Aviv University Ltd.
Israel
Patent: 4
Abalos Therapeutics GmbH
Nordrhein-Westfalen, Germany
Patent: 4
Centre Hospitalier Regional et Universitaire De Brest
France
Patent: 4
Universidad Nacional Autónoma de México
Distrito Federal, Mexico
Patent: 4
Synthon BV
Gelderland, Netherlands
Patent: 4
Euro-Celtique SA
Luxembourg, Luxembourg
Patent: 4
Duke University
North Carolina, United States
Patent: 3
Research Institutions
Order by:
Innovation Intensity
With the analysis among 204 patents, we discovered top 74 universities and scientific research institutions by total patent application. Université de Bretagne Occidentale, University of Lodz, Vlaams Instituut voor Biotechnologie - Flanders Institute are dominant in this area. They take 16.18% of the total patent filing.
Université de Bretagne Occidentale
France
Patent: 6
University of Lodz
Poland
Patent: 5
Vlaams Instituut voor Biotechnologie - Flanders Institute
Belgium
Patent: 5
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 4
Ghent University
Oost-Vlaanderen, Belgium
Patent: 4
Fudan University
Shanghai Shi, China
Patent: 4
Universidad Nacional Autónoma de México
Distrito Federal, Mexico
Patent: 4
President & Fellows of Harvard College
Massachusetts, United States
Patent: 4
Duke University
North Carolina, United States
Patent: 3
Thomas Jefferson University
Pennsylvania, United States
Patent: 3
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: